570 results on '"Vincentelli, André"'
Search Results
2. Definitions of major bleeding for predicting mortality in critically ill adult patients who survived 24 hours while supported with peripheral veno-arterial extracorporeal membrane oxygenation for cardiogenic shock: a comparative historical cohort study
3. Outcomes After Transcatheter Mitral Valve Replacement According to Regurgitation Etiology
4. Transapical Mitral Valve Replacement: 1-Year Results of the Real-World Tendyne European Experience Registry
5. Right Ventriculoarterial Coupling Surrogates and Long-Term Survival in LVAD Recipients: Results of the ASSIST-ICD Multicentric Registry
6. Implantation Technique for the Aeson Total Artificial Heart
7. Clinical utility of a deep-learning mortality prediction model for cardiac surgery decision making
8. Modulation of inflammatory M1-macrophages phenotype by valvular interstitial cells
9. Integrating Echocardiography Parameters With Explainable Artificial Intelligence for Data-Driven Clustering of Primary Mitral Regurgitation Phenotypes
10. Incidence, source, and prognostic impact of major bleeding across the spectrum of aortic stenosis
11. Clinical significance of myocardial contraction fraction in significant primary mitral regurgitation
12. Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study
13. Letter by Moussa et al Regarding Article, “Exposure to Arterial Hyperoxia During Extracorporeal Membrane Oxygenator Support and Mortality in Patients With Cardiogenic Shock”
14. Heparin Dosing Regimen Optimization in Veno-Arterial Extracorporeal Membrane Oxygenation: A Pharmacokinetic Analysis
15. Réhabilitation améliorée après chirurgie cardiaque adulte sous CEC ou à cœur battant 2021
16. Thrombus formation during ECMO: Insights from a detailed histological analysis of thrombus composition
17. Guidelines on enhanced recovery after cardiac surgery under cardiopulmonary bypass or off-pump
18. Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: a bicenter retrospective propensity score-weighted analysis
19. Clonal Hematopoiesis Is Associated With Long-Term Adverse Outcomes Following Cardiac Surgery.
20. Définitions de l’hémorragie majeure pour prédire la mortalité chez la patientèle adulte gravement malade ayant survécu 24 heures sous oxygénation par membrane extracorporelle veino-artérielle périphérique pour un choc cardiogénique : une étude de cohorte historique comparative
21. Comparison of Outcomes and Mortality in Patients Having Left Ventricular Assist Device Implanted Early -vs- Late After Diagnosis of Cardiomyopathy
22. Septuagenarian population has similar survival and outcomes to younger patients after left ventricular assist device implantation
23. Clinical application and management of temporary mechanical circulatory support: A clinical consensus.
24. Relation of Body Mass Index to Outcomes in Patients With Heart Failure Implanted With Left Ventricular Assist Devices
25. Outcomes of Left Ventricular Assist Device Implantation in Patients With Uncommon Etiology Cardiomyopathy
26. Diagnosis and management of heparin-induced thrombocytopenia
27. Clinical utility of a deep-learning mortality prediction model for cardiac surgery decision making
28. Comments on ‘Comparison of anticoagulation strategies for veno-venous ECMO support in acute respiratory failure’: the bitter truth about unfractionated heparin monitoring assays
29. Anti-Xa activity and hemorrhagic events under extracorporeal membrane oxygenation (ECMO): a multicenter cohort study
30. Quel bénéfice de l’angioplastie coronaire programmée pour le traitement de la maladie coronaire stable ?
31. Early Ventricular Arrhythmias After LVAD Implantation Is the Strongest Predictor of 30-Day Post-Operative Mortality
32. Gestion des agents antiplaquettaires en cas de procédure invasive non programmée ou d’hémorragie. Propositions du Groupe d’intérêt en hémostase périopératoire (GIHP) et du Groupe français d’études sur l’hémostase et la thrombose (GFHT) en collaboration avec la Société française d’anesthésie et de réanimation (SFAR)
33. von Willebrand Factor and Management of Heart Valve Disease: JACC Review Topic of the Week
34. Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society for Anaesthesia and Intensive Care (SFAR)
35. Position du GIHP sur les tests viscoélastiques : quelle place pour quelle indication en situation hémorragique ?
36. Gestion des agents antiplaquettaires pour une procédure invasive programmée. Propositions du Groupe d’intérêt en hémostase périopératoire (GIHP) et du Groupe français d’études sur l’hémostase et la thrombose (GFHT) en collaboration avec la Société française d’anesthésie-réanimation (SFAR)
37. Shear Forces Induced Platelet Clearance Is a New Mechanism of Thrombocytopenia
38. Human Aortic Valve Interstitial Cells Display Proangiogenic Properties During Calcific Aortic Valve Disease
39. Real-Time Monitoring of von Willebrand Factor in the Catheterization Laboratory: The Seatbelt of Mini-Invasive Transcatheter Aortic Valve Replacement?
40. Predictors and Clinical Impact of Late Ventricular Arrhythmias in Patients With Continuous-Flow Left Ventricular Assist Devices
41. Management of antiplatelet therapy in patients undergoing elective invasive procedures. Proposals from the French Working Group on perioperative haemostasis (GIHP) and the French Study Group on thrombosis and haemostasis (GFHT). In collaboration with the French Society for Anaesthesia and Intensive Care Medicine (SFAR)
42. Prospective assessment of the frequency of low gradient severe aortic stenosis with preserved left ventricular ejection fraction: Critical impact of aortic flow misalignment and pressure recovery phenomenon
43. Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support
44. Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the French Society for Anesthesia and Intensive Care (SFAR)
45. Suicide Attempts Among LVAD Recipients: Real-Life Data From the ASSIST-ICD Study
46. Impact of Prone Position in COVID-19 Patients on Extracorporeal Membrane Oxygenation*
47. Relationship between exercise pressure gradient and haemodynamic progression of aortic stenosis
48. Hematopoietic Somatic Mosaicism Is Associated With an Increased Risk of Postoperative Atrial Fibrillation
49. Quantification of primary mitral regurgitation by echocardiography: A practical appraisal
50. Drug-induced aortic valve stenosis: An under recognized entity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.